Abstract:Introduction Donor hematopoietic stem cell (DHSC) infusions are increasingly being studied in transplant patients for tolerance induction. Methods To analyze the fate of infused DHSCs in patients, we developed an in vitro culture system utilizing CD34 + DHSCs stimulated with irradiated allogeneic cells in cytokine supplemented medium long-term. Results Flow cytometric analyses revealed loss of the CD34 marker and an increase in CD33 + myeloid and CD3 + T-cell proportion by 10.4% and 72.7%, respectively, after 21 days in culture. T-cells primarily expressed TcR-αβ and were of both CD4 + and CD8 + subsets. Approximately 80% of CD3 + T cells lacked expression of the co-stimulatory receptor CD28. The CD4 + compartment was predominated by CD4 + CD25 + CD127-FOXP3 + Tregs (>50% CD4 + CD127- compartment) with <1% of all leukocytes exhibiting a CD4 + CD127 + phenotype. Molecular analyses for T-cell receptor excision circles showed recent and increased numbers of TcR rearrangements in generated T cells over time suggesting de novo differentiation from DHSCs. CD33 + myeloid cells mostly expressed HLA-DR, but lacked expression of co-stimulatory receptors CD80 and CD83. When studied as modulators in primary mixed lymphocyte reactions where the cells used to stimulate the DHSC were used as responders, the DHSC-lines and their purified CD8 + , CD4 + , CD33 + and linage negative subsets inhibited the responses in a dose-dependent and non-specific fashion. The CD8 + cell-mediated inhibition was due to direct lysis of responder cells. Discussion Extrapolation of these results into the clinical situation would suggest that DHSC infusions into transplant recipients may generate multiple subsets of donor “chimeric” cells and promote recipient Treg development that could regulate the anti-donor immune response in the periphery. These studies have also indicated that T cell maturation can occur in vitro in response to allogeneic stimulation without the pre-requisite of a thymic-like environment or NOTCH signaling stimulatory cell line.

Studies on a Nuclease from Azotobacter agilis II. HYDROLYSIS OF RIBONUCLEIC AND DEOXYRIBONUCLEIC ACIDS

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources

Tolerogenic dendritic cells in organ transplantation

Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy

Simplified Method to Generate Large Quantities of Dendritic Cells Suitable for Clinical Applications

Mixed glandular-neuroendocrine cancer of the gallbladder. Report of a case

TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation

Interlaboratory comparison of determinations of trace level hydrocarbons in mussels.

Characterization of Regulatory Dendritic Cells That Mitigate Acute Graft-versus-Host Disease in Older Mice Following Allogeneic Bone Marrow Transplantation

Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product

Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD

Conferring alloantigen specificity to regulatory T cells: A comparative analysis of cell preparations undergoing clinical development in transplantation

T Regulatory Cells As an Immunotherapy for Transplantation

Anti-ICAM-1 Antibody and CTLA-4Ig Synergistically Enhance Immature Dendritic Cells to Induce Donor-Specific Immune Tolerance in Vivo

T regulatory cells as an immunotherapy for transplantation.

Relative fitness of s-triazine susceptible and resistant biotypes of Chenopodium album

Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer.

MicroRNA expression in bovine preimplantation embryos.

Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy